Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pharma

From Legacy Systems to AI Ready Ecosystems in Global Life Sciences

Sujit Murumkar is a visionary leader who designed and implemented enterprise scale modern data ecosystems for one of the largest pharmaceutical organization, describing the digital transformation facing life sciences companies worldwide.

International Business Times

Analysis: Trump's trade and tax policies set to widen EU-US innovation gap in 2026

Companies say the EU’s deregulation efforts are insufficient against Trump's “carrot-and-stick” strategy of pairing generous US tax incentives with a punitive 15% tariff on imports from the EU.

Euronews

RFK Jr. sends ‘thousands of letters’ to drug companies over ‘misleading’ ads that ‘distorted physician prescribing habits’

Those happy pill ads with dancing patients? Trump's administration says they're basically lying to you.

We Got This Covered

From analysis to the latest developments in health,
read the most diverse news in one place.

'Pharma Bro' CEO Jacked Price of A Life-Saving Drug From $13.50 to $750 Per Pill Overnight — And His Reason? 'We Needed to Turn a Profit'

Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill.

Benzinga

Laura Loomer’s MAGA critics accuse her of being funded by Big Pharma

‘I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent

The Independent UK

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the…

Benzinga

Thomas Massie's New Bill Would Let People Sue Pharma for COVID Vaccine Injuries

Federal liability protections currently prevent people suing COVID-19 vaccine makers, and instead require them to request compensation from a program that's covered only 39 COVID vaccine injury claims.

Reason

Read news from The Economist, FT, and more,
with one subscription

Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?

Shares of Evoke Pharma Inc (NASDAQ:EVOK) are trading sharply higher Wednesday morning after the specialty pharmaceutical company announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a new patent covering its lead product, GIMOTI.

Benzinga

Former CDC nominee goes scorched earth, blaming two Republicans and ‘big Pharma’ for failed bid

Weldon’s nomination to head the CDC was withdrawn just 12 hours before he was supposed to testify to the Senate health committee

The Independent UK

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup

Most individuals diagnosed with a rare disease won’t live to become teenagers or adults. I knew what I had to do.

Fortune

£20m initiative to tackle ‘historically low’ numbers in dementia clinical trials

The Dementia Trials Accelerator will allow ‘tens of thousands’ to take part in trials.

The Independent UK

Doctors rarely understand how influence really works. The result: an NHS bowing to the needs of big pharma

There must be transparency over funding to medics from the pharmaceutical industry – and that’s only the start, says the GP and writer Margaret McCartney

The Guardian - UK

Sienna Miller’s £19 French skincare secret to achieving a glowing complexion

Sienna Miller has hailed this affordable retinol cream as the "French secret to great skin" and is a must-have in your beauty bag...

Woman & Home

'Pharma Bro' behind DJT crypto token, no proof Barron Trump involved

A Twitter sleuth exposed Martin Shkreli's ties to DJT, an unauthorized Trump memecoin.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

30-year-old worker dead, about eight employees injured when Pharma bus hits stationed lorry at Lankelapalem

30-yr-old worker dies, 8 injured in Anakapalli road accident. Cause suspected to be overspeeding. Unauthorised parking of lorries alleged to be cause of accidents. Family of deceased demands compensation.

StockNews.com

Under $15 Bargains: 3 Pharma Stocks to Watch

The pharmaceutical industry is anticipated to remain resilient, owing to increasing healthcare expenditure. Given this backdrop, it could be wise to watch quality pharma stocks Organon & Co. (OGN), GoodRx Holdings (GDRX), and Viatris (VTRS) trading under $15 now. Read on….

Chicago Sun-Times

Fast-paced ‘Painkiller’ depicts the making, selling and often devastating effects of OxyContin

Netflix limited series recounts Purdue Pharma’s work on the addictive drug from the perspective of its leader, some sellers, an investigator and a victim.

Reason

Did Fox Really Fire Tucker Carlson for Crossing the 'Red Line' of Criticizing Big Pharma, as RFK Jr. Claims?

If so, the network failed to enforce the supposed rule before and after cancelling its top-rated host.

Get all your
news in one place.

100’s of premium titles.
One news app.

Birmingham Post

Croda's sales top £2b as profits hit £500m for East Yorkshire smart science giant

Powerful operating model and consistent execution hailed as record performance revealed

Benzinga

'Pharma Bro' Martin Shkreli Is Chilling At A Halfway House After Being Released From Prison

Well-known fraudster Martin Shkreli is hanging out at a halfway house after he was released from federal prison on Wednesday. What To Know: According to several reports, citing Shkreli's lawyer, the "Pharma bro" was released from prison after serving a little more than four years of his seven-year sentence.

The Times of India

Sensex, Nifty fall over 1% as markets extend losses for third day

NEW DELHI: Equity indices plunged for the third straight session on Thursday with the benchmark BSE sensex falling over 600 points dragged by losses in IT and pharma stocks.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.